Yervoy, a new cancer drug that has been approved for the treatment of late-stage melanoma – and that is being used to treat other cancers in ongoing clinical trials – is based on a strategy for boosting the immune response developed and tested by scientists from UCSF and UC Berkeley.
February 23, 2011
UCSF pediatric endocrinologist Steve Gitelman leads type 1 diabetes clinical trials with the goal of halting beta cell destruction and thereby stopping the progression of disease soon after it is diagnosed.
December 13, 2010
UCSF physicians are combating a devastating side effect of chemotherapy with an innovative new program -- “Hair to Stay” -- to evaluate devices that could reduce scalp hair loss in breast cancer patients.
August 16, 2010
A UCSF-led team has discovered at least one key reason why blood stem cells are susceptible to developing the genetic mutations that can lead to adult leukemia.
August 12, 2010
A mutation found in a mouse gene that also appears in humans might provide new insights into the genetic roots of alcoholism, according to a study led by researchers at the Ernest Gallo Clinic and Research Center and UCSF. The study appears in the August 12, 2010, edition of “PLoS Genetics.”
July 14, 2010
A commercial brain fitness program has been shown to improve memory in older adults, at least in the period soon after training. The findings are the first to show that practicing simple visual tasks can improve the accuracy of short-term, or “working” visual memory.
May 03, 2010
To fight the “diseases of civilization,” a Paleolithic diet filled with fruits, vegetables, leafy greens, nuts, fish and lean meat shows early promise -- but imagine no grains, beans or dairy products.
April 07, 2010
An international study published in the March 25 New England Journal of Medicine showed what researchers call a clinical breakthrough in one of the greatest unmet needs for patients with advanced liver disease.
March 18, 2010
Taking an innovative path toward personalized medicine, scientists for the first time will be able to eliminate – at an early point in a clinical trial — experimental drugs that show poor efficacy, dramatically shortening the time it takes to get the right medication to the right patient with breast cancer.
March 03, 2010
New UCSF clinical trial tests intermittent high-dosage treatment for HER2-positive breast cancers.